Jul 6, 2021
Emma Morris and Iain McGill uncover the fascinating story behind Quell Therapeutics, revealing how a team of 6 top scientists came together to develop a pioneering cell and gene therapy that harnesses the body's immune response to prevent life-threatening organ transplant rejection. In this episode, we cover the...
Jun 28, 2021
Karen Petersen shares her inspiring story, mapping her journey from cancer survivor to founder of Karen's Club – a not-for-profit designed to support patients of color considering taking part in oncology clinical trials. She explores challenging topics, including building trust in marginalized communities, to reveal...
Jun 21, 2021
Building a successful healthcare start-up takes tremendous amounts of time, knowledge, and funding – and new ventures face roadblocks at every turn. So, how do entrepreneurs navigate this incredibly complex market? Frank Jaskulke, Vice President of Intelligence at The Medical Alley Association, shares the lessons...
Jun 14, 2021
Approximately 80% of clinical research and genomic studies consist of data from Caucasian participants. Roche and Genetech are determined to change that. Nicole Riche, Global Head of Health Equity and Population Science, reveals how her team developed a pioneering global strategy to address healthcare disparities across...
Jun 7, 2021
The rare disease diagnostic odyssey lasts on average 4.5 years. But what would happen if a novel innovation could diagnose a person with a rare disease instantaneously? Vanessa Lemarié, Director of Life Sciences Business Development and Program Owner of the Rare Disease Initiative at Ada Health, explains how the...